Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy

<div>Flow diagram of the study population. The figure shows the TRIAGE III study population and the composition of the groups, with regard to the presence (suPAR group) and absence (control group) of suPAR in patients acutely admitted to two emergency departments (EDs) studied in this study.</div>

Disease Markers

fig1

Figure 1

Figure 1: Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy 

Figure 1 | Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy 